Jana Tlapáková

Jana Tlapáková

The AZV ČR Newsletter has been published

We have prepared this year's second issue of the ČR Health Research Agency newsletter, which summarizes the most important events of the past six months. We have seen record interest in the VES 2026/J competition – the number of project proposals submitted has increased by almost 20%, with support...

Publication of the second joint transnational call of the ERDERA (European Rare Diseases Research Alliance) partnership: "Resolving unsolved cases in rare genetic and non-genetic diseases"

The Ministry of Health (hereinafter referred to as "MZD") publishes on December 10, 2025, in accordance with Act No. 130/2002 Coll., on support for research, experimental development, and innovation from public funds and on amendments to certain acts, the following December 2025, in accordance with Act No. 130/2002 Coll., on the support of research, experimental development, and innovation from public funds and on amendments to certain related acts (Act on the Support of Research, Experimental Development, and Innovation), in...

AZV organizes webinar on PerMed, THCS and ERDERA partnership calls

In connection with the announcement of the transnational call of the PerMed Partnership, the THCS Partnership and the ERDERA Partnership, a webinar will be organised on 12 December 2025 at 10.00. The aim of the webinar is to inform about the conditions for Czech applicants to participate in the calls, mandatory annexes and other documents. The webinar...

Publication of the joint multinational call of the PerMed EP Partnership: 'Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN 2026)'

On 25 November 2025, the Ministry of Health (hereinafter referred to as the "MZD") publishes, in accordance with Act No. 130/2002 Coll., on support for research, experimental development and innovation from public funds and on amendments to certain related acts (Act on support for research, experimental development and innovation),...